Inhibition of tubulin polymerization by select alkenyldiarylmethanes.
Inhibition of tubulin polymerization by select alkenyldiarylmethanes.
复制标题
通过选择烯基二芳基甲烷抑制微管蛋白聚合。
DOI：
10.1016/j.bmcl.2007.11.114
复制
发表时间：
2008
影响因子：
2.7
通讯作者：
Cushman,Mark
中科院分区：
文献类型：
--
作者：
Cullen,MatthewD;Sarkar,Taradas;Hamel,Ernest;Hartman,TracyL;Watson,KarenM;BuckheitJr,RobertW;Pannecouque,Christophe;DeClercq,Erik;Cushman,Mark
During studies on the alkenyldiarylmethane (ADAM) class of non-nucleoside reverse transcriptase inhibitors (NNRTIs), analogues were discovered that exhibit low micromolar and submicromolar cytotoxicities. Since the ADAMs are structurally related to the tubulin polymerization inhibitor CC-5079, a set of 14 ADAMs were tested for inhibition of tubulin polymerization in an attempt to identify the biological target responsible for their cytotoxicity. The results indicate that, overall, the ADAMs are poor inhibitors of tubulin polymerization. However, the two most cytotoxic compounds, 15 and 16, are in fact active as inhibitors of tubulin assembly with IC50values of 3.7±0.3 and 2.8±0.2μM, respectively, and they both inhibit the binding of colchicine to tubulin. Both compounds were investigated for anticancer activity in the National Cancer Institute’s panel of 60 human cancer cell lines, and both compounds consistently displayed submicromolar cytotoxicities with mean-graph midpoint (MGM) values of 0.31±0.08 and 0.47±0.09μM, respectively.
